Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
UKB NewsRoom | Annkristin Heine
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
CIO Bonn - Lymphomzentrum
ONLINE Cluster Lecture Series
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Team | IMMEI
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text